Gainers
- Ra Medical Systems, Inc. (NASDAQ:RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
- Rubicon Technology, Inc. (NASDAQ:RBCN) shares jumped 64% to $14.84 after the company announced that it entered into a definitive stock purchase and sale agreement with Janel Corporation.
- Maris-Tech Ltd. (NASDAQ:MTEK) gained 50% to $1.74 after the company received a purchase order from SpaceIL for the development of a video recording, streaming and image processing solution for the Beresheet 2 Lunar Mission.
- ZW Data Action Technologies Inc. (NASDAQ:CNET) climbed 47% to $0.4990.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares rose 33.6% to $4.7420 after jumping over 36% on Friday.
- Onion Global Limited (NYSE:OG) surged 32.8% to $1.13. Onion Global generated more than RMB14.8 million in GMV within the first three days of its 2022 Luca Brand Shopping Festival.
- Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 30% to $9.84 after dropping 16% on Friday.
- Cowen Inc. (NASDAQ:COWN) rose 24.5% to $29.93.
- Uxin Limited (NASDAQ:UXIN) gained 22.8% to $0.5528. Uxin recently announced entry into definitive agreements for financing transaction of $100 million in replacement of the previously announced binding term sheet.
- Avadel Pharmaceuticals plc (NASDAQ:AVDL) surged 19.8% to $3.08. Avadel Pharmaceuticals recently announced its steps to explore every available pathway to accelerate the FDA approval of its lead drug candidate, FT218, before June 2023.
- Cognition Therapeutics, Inc. (NASDAQ:CGTX) gained 19.6% to $2.6899. Cognition Therapeutics recently dosed first patient in the SHIMMER study of lead drug CT1812, an experimental, orally delivered small molecule therapeutic intended to address the underlying biology of dementia with Lewy bodies (DLB).
- bluebird bio, Inc. (NASDAQ:BLUE) gained 19.3% to $5.11.
- Tyme Technologies, Inc. (NASDAQ:TYME) jumped 19.3% to $0.3225. Syros Pharmaceuticals has agreed to acquire TYME Technologies, including its pipeline assets and net cash, after accounting for wind-down and transaction expenses currently estimated to be approximately $60 million.
- Dyne Therapeutics, Inc. (NASDAQ:DYN) gained 17% to $8.43 after the company announced FDA clearance of its Investigational New Drug application for DYNE-251 for the treatment of Duchenne muscular dystrophy.
- Athenex, Inc. (NASDAQ:ATNX) surged 16.4% to $0.5038.
- Symbotic Inc. (NASDAQ:SYM) gained 16.4% to $13.84. Raymond James initiated coverage on Symbotic with an Outperform rating and announced a price target of $18.
- Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) surged 15.5% to $22.49. Amylyx Pharmaceuticals announced FDA plan to reconvene the advisory committee to review AMX0035 NDA for the treatment of ALS on September 7, 2022.
- Precigen, Inc. (NASDAQ:PGEN) gained 15.6% to $1.6307 after the company agreed to sell its subsidiary Trans Ova Genetics to URUS for $170 million in upfront cash.
- Talaris Therapeutics, Inc. (NASDAQ:TALS) rose 15.2% to $2.65. Morgan Stanley downgraded Talaris Therapeutics from Overweight to Equal-Weight and announced an $8 price target.
- Blue Star Foods Corp. (NASDAQ:BSFC) surged 15.1% to $1.37.
- DIRTT Environmental Solutions Ltd. (NASDAQ:DRTT) gained 14.5% to $1.2599.
- NewAge, Inc. (NASDAQ:NBEV) gained 13.6% to $0.2653. NewAge, last month, reported a review of strategic alternatives.
- Mercurity Fintech Holding Inc. (NASDAQ:MFH) jumped 13.6% to $0.7950.
- Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) gained 12.4% to $0.6555.
- OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) rose 10.8% to $2.05. OneConnect successfully listed on the Main Board of The Stock Exchange of Hong Kong Limited.
- Tupperware Brands Corporation (NYSE:TUP) gained 10.7% to $7.42.
- Scopus BioPharma Inc. (NASDAQ:SCPS) rose 9.7% to $0.4368 after declining over 7% on Friday.
- Soleno Therapeutics, Inc. (NASDAQ:SLNO) rose 9.4% to $0.1958 after dropping over 3% on Friday.
- Offerpad Solutions Inc. (NYSE:OPAD) rose 7.4% to $2.3850.
